CNSX:CCHW

CSE Bulletin: Delist - Columbia Care Inc. (CCHW)

Retrieved on: 
Tuesday, August 1, 2023
CSE, Mail order, Nightclub

Toronto, Ontario--(Newsfile Corp. - le 1 août/August 2023) -The common shares of Columbia Care Inc. will be delisted from the CSE at market close on August 2, 2023.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - le 1 août/August 2023) -The common shares of Columbia Care Inc. will be delisted from the CSE at market close on August 2, 2023.
  • The common shares will continue to trade on Cboe Canada.
  • Les actions ordinaires de Columbia Care Inc. seront radiées du CSE à la clôture du marché le 2 août 2023.
  • Les actions ordinaires continueront d'être négociées sur Cboe Canada.

Columbia Care to Report Second Quarter 2023 Results on August 14, 2023

Retrieved on: 
Tuesday, August 1, 2023
Biotechnology, Other Retail, Alternative Medicine, Online Retail, Manufacturing, Other Health, Health, Cannabis, Natural Resources, Other Manufacturing, Retail, Telephone, CSE, FSE, NEO, NLRB v. Kentucky River Community Care, Inc., EDT

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the second quarter ended June 30, 2023 before U.S. financial markets open on Monday, August 14, 2023.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the second quarter ended June 30, 2023 before U.S. financial markets open on Monday, August 14, 2023.
  • Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EDT to discuss financial and operating results for the second quarter of 2023.
  • After registering, instructions will be shared on how to join the call for those who wish to dial in.
  • A live audio webcast of the call will also be available in the Investor Relations section of the Company's website at https://investors.columbia.care/ or at https://edge.media-server.com/mmc/p/hhco3g37 .

Columbia Care Announces Date for Voluntary Delisting of Common Shares from CSE

Retrieved on: 
Tuesday, August 1, 2023
Biotechnology, Health, Natural Resources, Cannabis, Canada, NEO Exchange, CSE, FSE, Canadian Securities Exchange, NEO, NLRB v. Kentucky River Community Care, Inc., Security (finance)

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that, further to its press release dated July 31, 2023, it will voluntarily delist its common shares from the facilities of the Canadian Securities Exchange (“CSE”), effective as of market close on August 2, 2023.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that, further to its press release dated July 31, 2023, it will voluntarily delist its common shares from the facilities of the Canadian Securities Exchange (“CSE”), effective as of market close on August 2, 2023.
  • Columbia Care will continue trading on the Cboe Canada, the new business name of the NEO Exchange.
  • Cboe Canada will remain the Company’s primary securities exchange, as it has been since the Company’s initial public listing.
  • Management of the Company expects that focusing trading activity on a single, senior exchange will allow for a more orderly closing price formation and greater transparency for the Company and its investors.

Cresco Labs and Columbia Care Mutually Agree to Terminate Merger

Retrieved on: 
Monday, July 31, 2023
Cannabis, Natural Resources, Other Retail, Retail, Hemp, Partnership, Cresco Labs, CSE, Core, FSE, CL, Labs, NEO, Security (finance)

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”) and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”) today announced a mutual agreement, dated July 30, 2023, to amicably terminate the definitive arrangement agreement dated March 23, 2022, as amended on February 27, 2023, pursuant to which Cresco agreed to acquire all of the issued and outstanding shares of Columbia Care (the “Transaction”).

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”) and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”) today announced a mutual agreement, dated July 30, 2023, to amicably terminate the definitive arrangement agreement dated March 23, 2022, as amended on February 27, 2023, pursuant to which Cresco agreed to acquire all of the issued and outstanding shares of Columbia Care (the “Transaction”).
  • “In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders.
  • We want to express our sincere gratitude to Columbia Care for their valuable collaboration and dedication during this transaction,” said Charles Bachtell, CEO and Co-founder of Cresco Labs.
  • We are thankful for the collaboration and partnership with the Cresco team throughout this extensive process,” said Nicholas Vita, CEO and Co-founder of Columbia Care.

Columbia Care Announces Corporate Actions to Accelerate Operational Efficiencies and Cash Flow Generation

Retrieved on: 
Monday, July 31, 2023
Biotechnology, Health, Natural Resources, Cannabis, Canada, CSE, Canadian Securities Exchange, Marketing, NEO Exchange, Telephone, Vita, Tax, FSE, GAAP, Sale, EBITDA, NEO, NLRB v. Kentucky River Community Care, Inc., Bank, Security (finance), Mobile phone

“Over the past 16 months, we have implemented important changes to Columbia Care that have resulted in a stronger and more efficient company.

Key Points: 
  • “Over the past 16 months, we have implemented important changes to Columbia Care that have resulted in a stronger and more efficient company.
  • Over the next 12 months, we intend to launch a number of initiatives to further our goals of ongoing margin improvement, free cash flow generation, driving shareholder value and profitably capturing additional market share across the country,” said Nicholas Vita, CEO of Columbia Care.
  • These operational improvements are expected to be cash flow positive in 2023 and 2024.
  • Effective today, Columbia Care has named David Hart as President & Chief Operating Officer and Jesse Channon as Chief Commercial Officer.

Columbia Care to Begin Adult Use Sales in Three Maryland Retail Locations on July 1

Retrieved on: 
Friday, June 30, 2023
Retail, Natural Resources, Cannabis, Food, Beverage, CSE, FSE, Amber, NEO, NLRB v. Kentucky River Community Care, Inc., Drug

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced it is set to begin adult use sales in its three Maryland retail locations, Columbia Care Chevy Chase, gLeaf Rockville and gLeaf Frederick, on Saturday, July 1.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced it is set to begin adult use sales in its three Maryland retail locations, Columbia Care Chevy Chase, gLeaf Rockville and gLeaf Frederick, on Saturday, July 1.
  • “The start of adult use sales in Maryland is a truly momentous occasion for our customers and for the industry as a whole.
  • We continue to see some states taking immediate action on ballot initiatives across the country and working diligently to put a framework together to build a broader, safer and more inclusive cannabis marketplace with the introduction of adult use sales.
  • Columbia Care brands that are now available in Maryland include Amber, Classix, gLeaf, Hedy, and Triple Seven.

Cresco Labs and Columbia Care Provide Update on Transaction

Retrieved on: 
Friday, June 30, 2023
Cannabis, Natural Resources, Labs, Cresco Labs, CSE, CL, NEO

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”), today announced that they will not be able to complete the divestitures necessary to secure all necessary regulatory approvals to close the pending transaction by the outside date of June 30, 2023 that is specified in the arrangement agreement dated March 23, 2022 and amended on February 27, 2023.

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), and Columbia Care (NEO:CCHW) (CSE:CCHW) (OTCQX:CCHWF) (“Columbia Care”), today announced that they will not be able to complete the divestitures necessary to secure all necessary regulatory approvals to close the pending transaction by the outside date of June 30, 2023 that is specified in the arrangement agreement dated March 23, 2022 and amended on February 27, 2023.
  • At this stage, Cresco and Columbia Care are working amicably with respect to the next steps in relation to the transaction and will provide further updates in the near future.

Columbia Care Announces Resignation of Philip Goldberg as Director

Retrieved on: 
Wednesday, June 14, 2023
Biotechnology, Food Tech, Natural Resources, Health, Technology, Food, Beverage, Cannabis, Retail, Agreement, Plan, CSE, FSE, Acquisition, Scaly-breasted lorikeet, NEO, NLRB v. Kentucky River Community Care, Inc., Security (finance)

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced the resignation of Philip Goldberg as director of the Company, which was effective June 12, 2023.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced the resignation of Philip Goldberg as director of the Company, which was effective June 12, 2023.
  • Mr. Goldberg was appointed to the board of directors of the Company pursuant to a Nominating Rights and Voting Agreement dated June 11, 2021 (the “Voting Agreement”) entered into in connection with Columbia Care’s acquisition of Green Leaf Medical, LLC (“Green Leaf”) pursuant to the Agreement and Plan of Merger dated December 21, 2020 among Columbia Care, Green Leaf and certain other parties thereto (the “Green Leaf Transaction”).
  • Subject to any obligations it may have under the Voting Agreement, the Company does not intend to appoint a new director to replace Mr. Goldberg.
  • The time period relevant to the last potential milestone payment concludes on June 30, 2023, at which point Green Leaf will be fully integrated into Columbia Care.

Columbia Care Reports First Quarter 2023 Results

Retrieved on: 
Monday, May 15, 2023
Technology, Cannabis, Specialty, Biotechnology, Food, Beverage, Health, Retail, Food Tech, Natural Resources, Capital expenditure, Cresco Labs, Genetics, Colonial Heights, Model Business Corporation Act, Telephone, Disclosure, Arrangement, CBD, Hampton, Growth, Yoy, Seed, Adjustment, THC, Bank, Rare-earth element, Tunnel, Video game, Agriculture, Security (finance)

[2]Excludes $0.6 million in Q1 2023 and $5.6 million in Q4 2022; see the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023 for additional disclosure.

Key Points: 
  • [2]Excludes $0.6 million in Q1 2023 and $5.6 million in Q4 2022; see the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023 for additional disclosure.
  • In furtherance of the Arrangement Agreement, Columbia Care continues to collaborate closely with Cresco Labs on the divestiture transactions required to obtain the regulatory approvals which are conditions of closing of the Arrangement.
  • The Company will host a conference call on Monday, May 15, 2023 at 8:00 a.m.
  • ET to discuss financial and operating results for the first quarter of 2023.

Columbia Care to Report First Quarter 2023 Results on May 15, 2023

Retrieved on: 
Tuesday, May 2, 2023
Food Tech, Cannabis, Retail, Technology, Natural Resources, Specialty, Food, Beverage, Telephone, CSE, EST, FSE, NEO, NLRB v. Kentucky River Community Care, Inc.

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the first quarter ended March 31, 2023 before U.S. financial markets open on Monday, May 15, 2023.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the first quarter ended March 31, 2023 before U.S. financial markets open on Monday, May 15, 2023.
  • Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EST to discuss financial and operating results for the first quarter of 2023.
  • After registering, instructions will be shared on how to join the call for those who wish to dial in.
  • A live audio webcast of the call will also be available in the Investor Relations section of the Company's website at https://investors.columbia.care/ or at https://edge.media-server.com/mmc/p/kfcj9amv .